Literature DB >> 22460772

Epidemiology of sepsis in pediatric intensive care units: first Colombian multicenter study.

Juan C Jaramillo-Bustamante1, Alejandro Marín-Agudelo, Mauricio Fernández-Laverde, José Bareño-Silva.   

Abstract

OBJECTIVES: In 2002, the Surviving Sepsis Campaign pointed out the need to recognize sepsis as an important cause of death and high economic and social costs. There are few epidemiologic studies of this disease in pediatrics and none in Colombia. The objective of this study was to describe the sociodemographic and clinical characteristics of patients with sepsis who were admitted at participating pediatric intensive care units.
DESIGN: Prospective study. SETTING AND PATIENTS: A Web site, http://www.sepsisencolombia.com, was created, in which 19 pediatric intensive care units from the ten principal cities in the country reported epidemiologic data about patients with sepsis between March 1, 2009, and February 28, 2010.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: There were 1,051 patients. Of these, 55% were male. Fifty-six percent came from urban areas. Fifty-six percent were <2 yrs of age. Seventy-six percent belonged to a low socioeconomic strata and 44% received government-subsidized health insurance. Forty-eight percent of patients had septic shock, 25% severe sepsis, and 27% sepsis. Forty-three percent were diagnosed with multiple organ dysfunction syndrome. In 54%, the infection was of respiratory origin followed by the abdomen as the site of origin in 18% of the patients. In almost 50%, the etiological agent was detected with Gram-negative bacteria being the most frequent and of highest mortality. Fifty percent had some type of relevant pathologic antecedent. Eleven percent had an invasive device on admission. Sixty-eight percent of the patients required mechanical ventilation. Mortality rate was 18%. The most important risk factors for mortality were age under 2 yrs, presence of shock or multiple organ dysfunction syndrome, and presence of Gram-negative bacteria.
CONCLUSIONS: Sepsis is common in Colombian pediatric intensive care units. Clear risk factors for getting sick and dying from this disease were identified. Mortality resulting from this disease is considerable for a developing society like ours.

Entities:  

Mesh:

Year:  2012        PMID: 22460772     DOI: 10.1097/PCC.0b013e31823c980f

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  31 in total

1.  Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis.

Authors:  Bobby Tan; Judith Ju-Ming Wong; Rehena Sultana; Janine Cynthia Jia Wen Koh; Mark Jit; Yee Hui Mok; Jan Hau Lee
Journal:  JAMA Pediatr       Date:  2019-04-01       Impact factor: 16.193

2.  New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality.

Authors:  John C Lin; Philip C Spinella; Julie C Fitzgerald; Marisa Tucci; Jenny L Bush; Vinay M Nadkarni; Neal J Thomas; Scott L Weiss
Journal:  Pediatr Crit Care Med       Date:  2017-01       Impact factor: 3.624

3.  Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis.

Authors:  Scott L Weiss; Julie C Fitzgerald; Fran Balamuth; Elizabeth R Alpern; Jane Lavelle; Marianne Chilutti; Robert Grundmeier; Vinay M Nadkarni; Neal J Thomas
Journal:  Crit Care Med       Date:  2014-11       Impact factor: 7.598

4.  Risk factors and inpatient outcomes associated with acute kidney injury at pediatric severe sepsis presentation.

Authors:  Julie C Fitzgerald; Michelle E Ross; Neal J Thomas; Scott L Weiss; Fran Balamuth; Amanda Hyre Anderson
Journal:  Pediatr Nephrol       Date:  2018-06-14       Impact factor: 3.714

5.  High Levels of Morbidity and Mortality Among Pediatric Hematopoietic Cell Transplant Recipients With Severe Sepsis: Insights From the Sepsis PRevalence, OUtcomes, and Therapies International Point Prevalence Study.

Authors:  Robert B Lindell; Shira J Gertz; Courtney M Rowan; Jennifer McArthur; Florian Beske; Adrian Plunkett; Scott L Weiss; Neal J Thomas; Vinay M Nadkarni; Julie C Fitzgerald
Journal:  Pediatr Crit Care Med       Date:  2017-12       Impact factor: 3.624

Review 6.  Epidemiology of Pediatric Septic Shock.

Authors:  Daniela Carla de Souza; Flávia Ribeiro Machado
Journal:  J Pediatr Intensive Care       Date:  2018-12-28

7.  Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study.

Authors:  Scott L Weiss; Julie C Fitzgerald; John Pappachan; Derek Wheeler; Juan C Jaramillo-Bustamante; Asma Salloo; Sunit C Singhi; Simon Erickson; Jason A Roy; Jenny L Bush; Vinay M Nadkarni; Neal J Thomas
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

8.  Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.

Authors:  Jing-Hui Chen; Gao-Feng Yu; Shang-Yi Jin; Wen-Hua Zhang; Dong-Xu Lei; Shao-Li Zhou; Xing-Rong Song
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Vasopressin and copeptin levels in children with sepsis and septic shock.

Authors:  Jan Hau Lee; Yoke Hwee Chan; Oi Fah Lai; Janil Puthucheary
Journal:  Intensive Care Med       Date:  2013-01-24       Impact factor: 17.440

10.  Comparison of Pediatric Severe Sepsis Managed in U.S. and European ICUs.

Authors:  John S Giuliano; Barry P Markovitz; Joe Brierley; Richard Levin; Gary Williams; Lucy Chai See Lum; Tavey Dorofaeff; Pablo Cruces; Jenny L Bush; Luke Keele; Vinay M Nadkarni; Neal J Thomas; Julie C Fitzgerald; Scott L Weiss
Journal:  Pediatr Crit Care Med       Date:  2016-06       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.